Where does Cytogen, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cytogen, Inc. ranks #34,928 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cytogen, Inc. hold?

Cytogen, Inc. holds 7 US utility patents granted between 2016 and 2023, spanning 8 technology areas.

What is Cytogen, Inc.'s Innovation Score?

Cytogen, Inc. has an Innovation Score of 33.5 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cytogen, Inc. focus on?

Cytogen, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 7 patents, ranking #2,018 of 7,863 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Cytogen, Inc.'s patent grant rate increasing or decreasing?

Cytogen, Inc.'s recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cytogen, Inc.'s patents?

Cytogen, Inc.'s patents average 10.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cytogen, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cytogen, Inc.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cytogen ranks #34,928 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#34,928
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.5/100): 10.6
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34928 · Foreign Corporation #34,928 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,928/49,997
PHOTO-FINISH Cabin Air Group B V
CPC-NARROW G01N · 8 areas
INNOV-THIN 33.5/100
CLAIMS-PAR 10.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cabin Air Group B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cytogen’s 33.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (21%) Velocity 10.0 pts (30%) Breadth 10.0 pts (30%) Claim depth 6.3 pts (19%)

Qualcomm Incorporated · highest

85
Cytogen · this assignee

34
3D Lighting… · lowest

7

What this shows Cytogen's Innovation Score is 33.5/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cytogen?

Each dot is one of Cytogen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cytogen’s own 10.6 claims/patent is ABOVE the 9.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cytogen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cytogen's grants concentrate

Cytogen, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2016. By volume, Cytogen sits between Cybozu, Inc. and CalAmp Wireless Networks Corporation.

Cytogen's three-year grant acceleration

Cytogen, Inc. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cybozu

7
CYC Engineering

7
Cytec Industrial…

7
Cytogel Pharma

7
Cabin Air Group B…

7
Cable Laboratories

7
Cadillac Products…

7
Calamp Wireless N…

7
Cytogen ◀

7

What this shows Cytogen holds 7 patents at rank #34,760, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cytogen

By rank, the assignees closest to #34,760 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Cytogen's primary technology class.

Cytogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Cytogen, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	14.3%
2017	1	14.3%
2019	2	28.6%
2022	1	14.3%
2023	2	28.6%

Which technologies does Cytogen, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

G02B - Optical Elements, Systems OR Apparatus 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

B01D - Separation 1

G06T - Image Data Processing OR Generation, IN General 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cytogen, Inc.'s patent record in context - here's where to go next.

Cytogen, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 100% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #34,928 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cytogen, Inc. against Cybozu, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.